ElevateBio
Founded Year
2017Stage
Series C | AliveTotal Raised
$845MLast Raised
$525M | 2 yrs agoAbout ElevateBio
ElevateBio creates and operates a portfolio of cell and gene therapy companies to develop, manufacture and commercialize life-transforming medicines. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Missing: ElevateBio's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ElevateBio's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing ElevateBio
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned ElevateBio in 1 CB Insights research brief, most recently on May 13, 2020.
Expert Collections containing ElevateBio
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ElevateBio is included in 4 Expert Collections, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Drug Discovery Tech Market Map
221 items
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.
Digital Health
11,233 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma companies and and assistive tech developers.
ElevateBio Patents
ElevateBio has filed 1 patent.
The 3 most popular patent topics include:
- Acute myeloid leukemia
- Experimental cancer drugs
- Indoles
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/10/2020 | Olfactory receptors, Indoles, Transcription factors, Experimental cancer drugs, Acute myeloid leukemia | Application |
Application Date | 4/10/2020 |
|---|---|
Grant Date | |
Title | |
Related Topics | Olfactory receptors, Indoles, Transcription factors, Experimental cancer drugs, Acute myeloid leukemia |
Status | Application |
Latest ElevateBio News
Apr 25, 2023
WALTHAM, Mass. & DURHAM, N.C.--(BUSINESS WIRE)--Life Edit® Therapeutics Inc., an ElevateBio® company focused on next-generation gene editing technologies and therapeutics, today announced the presentation of the first preclinical data from the company's Huntington's disease program across three presentations at CHDI’s 18th Annual Huntington’s Disease Therapeutics Conference taking place April 24-27, 2023, in Dubrovnik, Croatia. Life Edit’s presentations underscore the ability of its gene editin
ElevateBio Frequently Asked Questions (FAQ)
When was ElevateBio founded?
ElevateBio was founded in 2017.
Where is ElevateBio's headquarters?
ElevateBio's headquarters is located at 200 Smith St, Cambridge.
What is ElevateBio's latest funding round?
ElevateBio's latest funding round is Series C.
How much did ElevateBio raise?
ElevateBio raised a total of $845M.
Who are the investors of ElevateBio?
Investors of ElevateBio include Matrix Capital Management, Fidelity Investments, SoftBank , Samsara BioCapital, F2 Ventures and 9 more.
Who are ElevateBio's competitors?
Competitors of ElevateBio include I Peace.
Compare ElevateBio to Competitors
Allele Biotechnology and Pharmaceuticals is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers. The company aims to increase accessibility to innovative molecular biology research tools by offering cutting edge products at a reasonable cost, and providing excellent customer service in addition to the technical knowledge needed to facilitate their use.
I Peace is a developer and manufacturer of human-induced pluripotent stem cells (iPS Cells) technologies. It is based in Palo Alto, California.
Lonza Group (SIX: LONN) (SGX: O6Z) is a chemicals and biotechnology company that provides product development services to the pharmaceutical and biologics industries, including organic, fine, and performance chemicals. It was founded in 1897 and is based in Basel, Switzerland.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.